Alzheimer’s Protein Atlas Reveals Microglial Protein Changes

Alzheimer's Disease, Alzheimer's Research, Alzheimer's Protein Atlas, Neurodegenerative Diseases, Neuroscience, Neurology Research, Proteomics, Cell-Specific Proteomics, Microglia, Astrocytes, Single-Cell RNA Sequencing, Spatial Omics, Brain Research, Protein Expression, St. Jude Children's Research Hospital, single-cell RNA sequencing, proteomic profiling, intercellular communication in the brain, neurodegenerative disease research, Alzheimer's molecular mechanisms, Alzheimer's therapeutic targets
Alzheimer's Protein Atlas Reveals Microglial Protein Changes

Key Highlights

  • St. Jude Children’s Research Hospital scientists developed the first cell-type-specific Alzheimer’s disease protein atlas using mouse models.
  • Researchers identified more than 3,000 proteins with altered levels across different brain cell types.
  • Approximately 78% of the identified protein changes had not been captured in previous studies.
  • Microglia showed particularly substantial changes, most of which were previously undetected.
  • The findings reveal potential communication networks between brain cells and offer new directions for Alzheimer’s disease research.
  • For More Updates in Neurology, register for the American Neurology Summit 2027 (ANS 2027)

Alzheimer’s Protein Atlas Reveals Cell-Specific Disease Changes

Researchers identify more than 3,000 altered proteins across brain cell types, uncovering previously undetected changes and potential cellular communication pathways linked to Alzheimer’s disease.

Scientists at St. Jude Children’s Research Hospital have developed the first cell-type-specific Alzheimer’s protein atlas, providing researchers with a more detailed understanding of how different brain cells respond to the disease. Using mouse models, the team identified more than 3,000 proteins with altered levels across multiple cell types, with approximately 78% of these changes not previously documented.

Published in Neuron, the findings offer new insights into Alzheimer’s disease pathology, particularly the molecular changes affecting microglia and the communication networks between different brain cells. The research could help identify potential disease drivers and targets for future therapeutic investigations.

Cell-Type-Specific Proteomics Reveals Previously Undetected Changes in Alzheimer’s

Understanding how Alzheimer’s disease affects individual brain cell populations remains a significant challenge. Although single-cell RNA sequencing has helped researchers examine cellular activity, it does not fully capture protein-level changes. Conventional proteomic studies, meanwhile, have largely relied on bulk tissue analysis, which can overlook differences between individual cell types.

To address these limitations, researchers combined next-generation mass spectrometry with single-cell RNA sequencing and spatial omics. Co-corresponding authors Junmin Peng, PhD, and Jiyang Yu, PhD, led the team in analyzing two Alzheimer’s disease mouse models across multiple ages and cell types.

The investigation profiled more than 13,000 proteins and identified thousands of cell-specific changes involving protein levels, biological pathways, and intercellular signaling networks.

Microglia, immune cells that help maintain brain health and are associated with several Alzheimer’s disease risk genes, showed particularly notable findings. Nearly all the protein-level changes identified in these cells had escaped detection in previous datasets.

These findings demonstrate how cell-type-specific proteomic profiling can reveal molecular changes that conventional approaches may miss.

RNA-Protein Differences Reveal Potential Brain Cell Communication

The researchers also identified differences between gene expression and protein abundance, providing additional insight into how brain cells interact during Alzheimer’s disease.

One notable example involved pleiotrophin, a protein associated with cellular signaling. Researchers detected higher RNA expression in astrocytes, while protein levels were higher in microglia. This difference suggests that astrocytes may produce and secrete pleiotrophin, allowing it to function in neighboring microglia.

Such findings point toward potential intercellular communication pathways that could influence disease-related processes.

The research team has made its atlas and accompanying datasets publicly accessible, providing a resource for investigators studying Alzheimer’s disease and related neurological conditions.

For More Updates in Neurology, register for the American Neurology Summit 2027 (ANS 2027)

 

For neurologists, neuroscientists, and clinical researchers, these findings highlight the importance of examining protein activity alongside gene expression. The integrated approach could support future investigations into cell-specific disease mechanisms, potential therapeutic targets, and molecular interactions involved in Alzheimer’s disease.

Source:

St. Jude Children’s Research Hospital

Medical Blog Writer, Content & Marketing Specialist

more recommended stories